Gene Sequencing tests in Dubai & UAE

Compare available Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

143

Listed price range

2,600.00–3,200.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Gene Sequencing test prices

Showing 46–60 of 143 matching tests.

Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4749 G6PC3 Gene Neutropenia (Severe Congenital Type 4, Autosomal Recessive) Genetic Test This genetic test evaluates the G6PC3 gene for pathogenic variants associated with severe congenital neutropenia type 4.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the G6PC3 gene", "Copy number variants in the G6PC3 gene"] Parameters [] Preparation ["Pre-test genetic counselling is strongly advised", "Construction of a family pedigree chart is strongly advised"] Indications ["Suspected severe congenital neutropenia type 4", "Family history of severe congenital neutropenia", "Evaluation for hematopoietic stem cell transplant eligibility"] Measurement technique Confirm with laboratory Codes LOINC: 21633-4 ICD-10: D70.0 Clinical summary This genetic test evaluates the G6PC3 gene for pathogenic variants associated with severe congenital neutropenia type 4.
TEST-4426 GABRD Gene Epilepsy, Idiopathic Generalized Type 10 Genetic Test This test evaluates the GABRD gene for pathogenic variants associated with idiopathic generalized epilepsy type 10.	Whole Blood (EDTA) or Saliva	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GABRD gene coding exons", "GABRD gene splice sites", "GABRD gene known deep intronic variants"] Parameters [] Preparation [] Indications ["Diagnosis of idiopathic generalized epilepsy type 10", "Family planning for individuals with epilepsy", "Risk assessment for relatives of individuals with epilepsy"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G40.309 Clinical summary This test evaluates the GABRD gene for pathogenic variants associated with idiopathic generalized epilepsy type 10.
TEST-4167 GABRG2 Gene Dravet Syndrome Genetic Test This genetic test analyzes the GABRG2 gene to identify variants associated with Dravet syndrome, a severe form of epilepsy.	Whole Blood (1–4 mL EDTA), Extracted DNA, or Dry Blood Spot on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic or likely pathogenic variants in the GABRG2 gene", "Copy Number Variations (CNV) within the GABRG2 gene"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist about blood-thinning medications"] Indications ["Suspected diagnosis of Dravet syndrome", "Evaluation of treatment-resistant epilepsy", "Genetic confirmation for personalized treatment strategies"] Measurement technique Confirm with laboratory Codes LOINC: 101186-7 ICD-10: G40.834 Clinical summary This genetic test analyzes the GABRG2 gene to identify variants associated with Dravet syndrome, a severe form of epilepsy.
TEST-6389 GALE Gene Galactose Epimerase Deficiency Genetic Test This genetic test identifies pathogenic variants in the GALE gene associated with galactose epimerase deficiency (galactosemia type III).	Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GALE gene", "Full coding region and intron-exon boundaries"] Parameters [] Preparation ["Pre-test genetic counselling session required", "Fasting is not mandatory", "Do not alter medications without physician approval"] Indications ["Confirmation of suspected galactose epimerase deficiency", "Carrier screening in families with a history of galactosemia", "Prenatal diagnosis", "Preimplantation genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E74.29 Clinical summary This genetic test identifies pathogenic variants in the GALE gene associated with galactose epimerase deficiency (galactosemia type III).
TEST-4019 GARS1 Gene CMT2D Next‑Generation Sequencing (NGS) Genetic Test This test identifies pathogenic variants in the GARS1 gene associated with Charcot-Marie-Tooth disease type 2D (CMT2D). It uses Next-Generation Sequencing (NGS) for comprehensive a...	Peripheral Whole Blood (EDTA), Extracted Genomic DNA, or Dried Blood Spot (FTA Card)	21–28 Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GARS1 gene variants", "SNVs", "Indels", "CNVs"] Parameters [] Preparation [] Indications ["Clinical suspicion of Charcot-Marie-Tooth disease type 2D (CMT2D)", "Family history suggesting autosomal dominant inheritance pattern"] Measurement technique Confirm with laboratory Codes LOINC: 95050-2 ICD-10: G60.0 Clinical summary This test identifies pathogenic variants in the GARS1 gene associated with Charcot-Marie-Tooth disease type 2D (CMT2D). It uses Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-1566 GATA2 Full-Length Gene Sequencing (Chronic Neutropenia, MonoMac Syndrome, Myelodysplasia, AML) Test This test analyzes the entire coding region of the GATA2 gene to detect mutations associated with GATA2 deficiency syndrome.	Venous blood draw or bone marrow aspirate	15 working days	3,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GATA2 gene variants", "Coding-region mutations", "Splice site variants"] Parameters [] Preparation ["No specific fasting required", "Inform physician of all current medications"] Indications ["Diagnosis of GATA2 deficiency syndrome", "Prognostic evaluation in suspected cases", "Surveillance for related hematologic malignancies"] Measurement technique Confirm with laboratory Codes LOINC: 68880-7 ICD-10: D61.81, D46.9, C92.0 Clinical summary This test analyzes the entire coding region of the GATA2 gene to detect mutations associated with GATA2 deficiency syndrome.
TEST-4134 GATA4 Gene Sequencing Test for Testicular Anomalies and Congenital Heart Disease (NGS) This test evaluates the GATA4 gene for variants associated with testicular anomalies and congenital heart disease.	Peripheral whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in GATA4", "Small insertions/deletions in GATA4", "Copy number changes in GATA4"] Parameters [] Preparation ["No fasting required", "Submit detailed clinical history form", "Submit three-generation pedigree", "Inform phlebotomy team if taking anticoagulants"] Indications ["Personal or family history of congenital heart disease", "Personal or family history of testicular anomalies", "Recurrent ventricular septal defect", "Atrial septal defect", "Tetralogy of Fallot"] Measurement technique Confirm with laboratory Codes LOINC: 94051-3 ICD-10: Z13.79 Clinical summary This test evaluates the GATA4 gene for variants associated with testicular anomalies and congenital heart disease.
TEST-3829 GH1 Gene Growth Hormone Deficiency Genetic Test This test sequences the entire GH1 gene to detect pathogenic variants associated with isolated growth hormone deficiency.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GH1 gene sequence", "Copy Number Variants (CNVs) in GH1 gene"] Parameters [] Preparation ["Provide detailed clinical history", "Mandatory pre-test genetic counselling session", "Informed consent required"] Indications ["Suspected isolated growth hormone deficiency", "Confirmation of genetic cause for short stature", "Family cascade screening for GH1 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E23.0 Clinical summary This test sequences the entire GH1 gene to detect pathogenic variants associated with isolated growth hormone deficiency.
TEST-4810 GJC2 Gene Hereditary Lymphedema Type IC Genetic Test This test identifies pathogenic variants in the GJC2 gene associated with hereditary lymphedema type IC.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GJC2 gene"] Parameters [] Preparation ["A detailed clinical history and family pedigree are required.", "Mandatory pre-test genetic counselling is arranged."] Indications ["Suspected hereditary lymphedema type IC", "Family history of hereditary lymphedema"] Measurement technique Confirm with laboratory Codes LOINC: 94801-1 ICD-10: Q82.0 Clinical summary This test identifies pathogenic variants in the GJC2 gene associated with hereditary lymphedema type IC.
TEST-5664 GJC2 Gene SPG44 Genetic Test This test evaluates the GJC2 gene for pathogenic variants associated with Hereditary Spastic Paraplegia Type 44 (SPG44). It identifies mutations that can cause progressive lower li...	Whole Blood, DNA FTA Card, or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GJC2 gene", "Coding region of the GJC2 gene", "Copy Number Variations (CNVs)", "Deep intronic variants"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed"] Indications ["Confirmation of SPG44 diagnosis", "Carrier screening", "Prenatal diagnosis", "Evaluation of unexplained progressive spastic paraplegia"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G11.4 Clinical summary This test evaluates the GJC2 gene for pathogenic variants associated with Hereditary Spastic Paraplegia Type 44 (SPG44). It identifies mutations that can cause progressive lower limb spasticity and weakness.
TEST-6351 GSTT1 Gene Glutathione S-Transferase Theta-1 Deficiency Genomic Test This test identifies complete deletions of the GSTT1 gene, which can impact detoxification capacity and oxidative stress levels.	Whole Blood (Peripheral Venous)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GSTT1 gene deletions", "Detoxification capacity", "Oxidative stress susceptibility"] Parameters [] Preparation [] Indications ["Cancer risk assessment", "Personalised nutrition planning", "Functional medicine detox protocols", "Anti-aging optimisation"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Z15.09, Z13.79 Clinical summary This test identifies complete deletions of the GSTT1 gene, which can impact detoxification capacity and oxidative stress levels.
TEST-5768 GSTZ1 Gene Tyrosinemia Type 1B Genetic Test This genetic test identifies pathogenic variants in the GSTZ1 gene associated with Tyrosinemia Type 1B.	Peripheral whole blood (EDTA) or genomic DNA extracted from blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GSTZ1 gene"] Parameters [] Preparation ["No fasting required", "No medication changes required unless directed by physician", "Pre-genetic counselling session required"] Indications ["Individuals with symptoms suggestive of tyrosinemia", "Family history of tyrosinemia Type 1B", "Carrier screening", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 92868-6 ICD-10: E70.21 Clinical summary This genetic test identifies pathogenic variants in the GSTZ1 gene associated with Tyrosinemia Type 1B.
TEST-3495 HADHB Gene Trifunctional Protein Deficiency Genetic Test This genetic test evaluates the HADHB gene for pathogenic variants associated with mitochondrial trifunctional protein deficiency.	Peripheral whole blood (EDTA) or buccal swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HADHB gene", "Copy number variants (CNVs) in the HADHB gene"] Parameters [] Preparation ["Mandatory genetic counseling session prior to collection", "No fasting required"] Indications ["Suspected mitochondrial trifunctional protein deficiency", "Family history of HADHB-related disorders", "Evaluation of fatty acid oxidation disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94222-7 ICD-10: E71.3 Clinical summary This genetic test evaluates the HADHB gene for pathogenic variants associated with mitochondrial trifunctional protein deficiency.
TEST-2340 HESX1 Gene Sequencing for Septo‑Optic Dysplasia Test This test identifies mutations in the HESX1 gene, providing a definitive molecular diagnosis for Septo-Optic Dysplasia (SOD).	Peripheral venous whole blood	21–28 working days (3–4 weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HESX1 gene sequence", "Mutations within HESX1 coding exons and flanking introns"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting physician"] Indications ["Suspected Septo-Optic Dysplasia", "Evaluation of pituitary hormone deficiencies", "Recurrence risk assessment in families with SOD"] Measurement technique Confirm with laboratory Codes LOINC: 81326-7 ICD-10: Q04.4 Clinical summary This test identifies mutations in the HESX1 gene, providing a definitive molecular diagnosis for Septo-Optic Dysplasia (SOD).
TEST-2396 HNRNPU Gene RNA Processing‑Related Disorders Genetic Test This test sequences the HNRNPU gene and its RNA transcripts to detect variants associated with intellectual disability, epilepsy, and syndromic dysmorphology.	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HNRNPU gene sequence", "RNA transcripts of HNRNPU gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Splicing variants"] Parameters [] Preparation [] Indications ["Suspected HNRNPU-related disorders", "Developmental regression", "Refractory seizures", "Multiple congenital anomalies"] Measurement technique Confirm with laboratory Codes LOINC: 95424-2 ICD-10: Q87.8, F70 Clinical summary This test sequences the HNRNPU gene and its RNA transcripts to detect variants associated with intellectual disability, epilepsy, and syndromic dysmorphology.

Category overview

Gene Sequencing: overview

Achieving a definitive diagnosis for a complex or rare genetic disorder often requires reading the entire genetic code of specific genes to find elusive, hidden errors. As a cornerstone of our advanced Genetics services, Gene Sequencing expansively scans the targeted regions of your genome to uncover rare or novel mutations that standard tests miss. Utilizing state-of-the-art sequencing technology, this comprehensive molecular profiling delivers the critical data necessary to safely guide your healthcare provider in tailoring highly personalized medical management and targeted therapeutic interventions. Trusted for molecular excellence among premier diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and remarkably fast reporting. Find the clear, definitive answers you need—schedule your gene sequencing testing in UAE, coordinate a seamless clinical sample transfer, or consult our expert medical genetics professionals today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.